What is ZTS's P/E ratio?

ZOETIS INC (ZTS) currently trades at a P/E ratio of 12.09.

ZOETIS INC reports a Return on Equity (ROE) of 81.75%.

What is ZTS's dividend yield?

ZOETIS INC offers a dividend yield of 2.60%.

What is ZTS's Quality Score?

Our AI rates ZTS's overall financial quality at 77 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ZTS?

Our AI Timing Score for ZTS is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ZTS belong to?

ZOETIS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange

ZTS (NYSE) Stock Analysis | ZOETIS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ZTS AI Analysis Summary

Our AI summary for ZTS: ZOETIS INC (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 12.09, ROE of 81.75%, a dividend yield of 2.60%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 50/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ZTS

ZOETIS INC

USD 77.29

1.26 (1.66%) Day Change

Watchlist Portfolio Compare Chart

12.09

P/E

2.80

D/E

81.8%

ROE

17.4%

ROA

2.60%

Div Yield

1.18

PEG

ZOETIS INC
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 77.29 Price 1.26 (1.66%) Day Change	NEWS SCORE: 82

ZTS, the overall quality is good ( Quality = 77) but the timing to buy is ...(Sign In to See)...

Loading chart...

77 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are ok , financial health is not good , and ability to make profit is good , ...

Quality Factors

63%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	82
Magic Formula Rank by ROA	273
Magic Formula Rank by ROE	273
Magic Formula Rank by ROIC	313
Price	77.29
PBV / Sector	9.88 / 3.22
Earning Per Share	6.39

PE / Sector	12.09 / 29.79 GOOD
PEG or PE/Growth / Sector	1.18 / 0.13
Average 1M Daily Value	366.78 M GREAT
Average 1W Daily Value	344.20 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

79%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	27.79 / 15.21 GREAT
NPM Average (%) / Sector	27.30 / -10.83 GREAT
NPM Change Average (%) / Sector	1.58 / 117.42
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	17.44 / 8.15 GOOD
ROA Average (%) / Sector	16.55 / 2.87 GOOD
ROA Change Average (%) / Sector	5.54 / 112.70
ROE (%) / Sector	81.75 / -1.02 GREAT
ROE Average (%) / Sector	61.80 / 8.35 GREAT
ROE Change Average (%) / Sector	16.17 / 385.91 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

41%

Dividend (%) / Sector	2.60 / 0.51
Dividend Average (%) / Sector	1.40 / 3.06
Dividend Change Average (%) / Sector	33.46 / 13.64 GREAT

Registration Details

Analyze Date	2026-08-01 08:00:45
Symbol	ZTS
Name	ZOETIS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NYSE
Listed Shares	419.23 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	31,945.18 / 10,754.62

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 10 Sylvan Way, Parsippany, NJ, United States, 07054

Phone: 973 822 7000

Website: https://www.zoetis.com

Employees: 14,500

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.